13G Filing: Armistice Capital and Actinium Pharmaceuticals Inc. (ATNM)

Item 4.

Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)

Amount beneficially owned:

Armistice Capital, LLC – 4,000,000

Armistice Capital Master Fund Ltd. – 4,000,000

Steven Boyd – 4,000,000

(b)

Percent of class:

Armistice Capital, LLC – 5.0%

Armistice Capital Master Fund Ltd. – 5.0%

Steven Boyd – 5.0%

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote

Armistice Capital, LLC – 0

Armistice Capital Master Fund Ltd. – 0

Steven Boyd – 0

(ii)

Shared power to vote or to direct the vote

Armistice Capital, LLC – 4,000,000

Armistice Capital Master Fund Ltd. – 4,000,000

Steven Boyd – 4,000,000

(iii)

Sole power to dispose or to direct the disposition of

Armistice Capital, LLC – 0

Armistice Capital Master Fund Ltd. – 0

Steven Boyd – 0

(iv)

Shared power to dispose or to direct the disposition of

Armistice Capital, LLC – 4,000,000

Armistice Capital Master Fund Ltd. – 4,000,000

Steven Boyd –4,000,000